Table of Contents:
  • Chair's introduction / Shomi Bhattacharya
  • Gene therapy of retinal dystrophies: achievements, challenges and prospects / Dean Bok
  • Identifying retinal disease genes: how far have we come, how far do we have to go? / Stephen P. Daiger
  • Dominant cone and cone-rod dystrophies: functional analysis of mutations in retGC1 and GCAP1 / David M. Hunt et al
  • Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration / Roxana A. Radu et al
  • Expanding roles of ABCA4 and CRB1 in inherited blindness / F.P.M. Cremers, A. Maugeri, A.I. den Hollander and C.B. Hoyng
  • What should a clinician know to be prepared for the advent of treatment of retinal dystrophies / Alan C. Bird
  • Role of subunit assembly in autosomal dominant retinitis pigmentosa linked to mutations in peripherin 2 / Robert S. Molday, Laurie L. Molday and Christopher J.R. Loewen
  • Search for rod-dependent cone viability factors, secreted factors promoting cone viability / Theirry LĂ©veillard et al
  • Studies on retinal and retinal pigment epithelial gene expression / Itay Chowers, Noriko Esumi, Peter Campochiaro and Donald J. Zack
  • From disease genes to cellular pathways: a progress report / J. Yu et al
  • Prospects for gene therapy / Robin R. Ali
  • General discussion
  • Range of retinal diseases potentially treatable by AAV-vectored gene therapy / William W. Hauswirth et al
  • Gene therapy for Leber congenital amaurosis / Jean Bennett
  • Index of contributors
  • Index.